Obesity and Weight Management
Manual of Clinical Nutrition Management III- 88 Copyright © 2013 Compass Group, Inc.
- Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or
metformin. N Engl J Med. 2002;346:393-403. - Kennedy ET, Bowman SA, Spence JT, Freedman M, King J. Popular diets: correlation to health, nutrition, and obesity. J Am Diet
Assoc. 2001;101:411-420. - Wadden T, Van Itallie T, Blackburn G. Responsible and irresponsible use of very-low-calorie diets in the treatment of obesity. JAMA.
1990;263:83-85. - Nonas C. A model for chronic care of obesity through dietary treatment. J Am Diet Assoc. 1998;98(suppl 2):S16-S22.
- Foster GD, Wyatt HR, Hill JO, McGuckin BG, Brill C, Mohammed BS, Szapary PO, Rader DJ, Edman JS, Klein S. A randomized trial of a
low-carbohydrate diet for obesity. N Engl J Med. 2003;348:2082-2090. - Physical activity guidelines advisory committee report to the Secretary of Health and Human Services, 2008. US Department of
Health and Human Services Web site. http://www.health.gov/PAGuidelines/committeereport.aspx. Accessed February 10, 2009. - National Task Force on the Prevention and Treatment of Obesity, National Institutes of Health. Very low-calorie diets. JAMA.
1993;270:967-974. - Wadden TA, Osei S. The treatment of obesity: an overview. In: Wadden TA, Stunkard AJ, eds. Handbook of Obesity Treatment. New
York: Guilford Press; 2002:229-248. - Flechtner-Mors M, Ditschuneit HH, Johnson TD, Suchard MA, Adler G. Metabolic and weight loss effects of long-term dietary
intervention in obese patients: four-year results. Obes Res. 2000;8:399-402. - National Task Force on the Prevention and Treatment of Obesity. Long-term pharmacotherapy in the management of obesity.
JAMA. 1996;276:1907-1915. - Fabricatore AN, Wadden TA. Treatment of obesity: an overview. Clin Diabetes. 2003;21:67-72.
- Fernstrom JD, Atkinson RL. Antiobesity agents: pharmacology and pharmacotherapy. In: Obesity as a Chronic Disease: New
Implications for Management. Clinical Management Conference Proceedings. Minneapolis, Minn: University of Minnesota Office of
Continuing Education; 1998:18-27. - Lean MEJ. Sibutramine: a review of clinical efficacy. Int J Obes. 1997;21:30S-36S.
- James WP, Astrup A, Finer N, Hilsted J, Kopelman P, Rossner S, Saris WH, Van Gaal LF. Effect of sibutramine on weight maintenance
after weight loss: a randomized trial. Lancet. 2000;356:2119-2125. - Wadden TA, Berkowitz RI, Sarwer DB, Prus-Wisniewski R, Steinberg C. Benefits of lifestyle modification in the pharmacologic
treatment of obesity: a randomized trial. Arch Intern Med. 2001;161:218-227. - Sjostrom L, Rissanen A, Andersen T, Boldrin M, Golay A, Koppeschaar HP, Krempf M. Randomised placebo-controlled trial of orlistat
for weight loss and prevention of weight regain in obese patients. Lancet. 1998;352:167-172. - Davidson MH, Hauptman J, DiGiorlamo M, Foreyt JP, Halstead CH, Heber D, Heimburger DC, Lucas CP, Robbins DC, Chung J,
Heymsfeld SB. Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled
trial. JAMA. 1999;281:235-242. - Mechanick JI, Surgerman HJ, Collazo-Clavell ML, Spitz AF, Livingston EH, Anderson WA. Executive Summary of The
Recommendations of The American Association of Clinical Endocrinologists, The Obesity Society, and American Society for
Metabolic & Bariatric Surgery Medical Guidelines For Clinical Practice for The Perioperative, Nutritional, Metabolic, and Nonsurgical
Support of The Bariatric Surgery Patient. Endocrine Practice. 2008;3:318-336. - MacLean LD, Rhode BM, Nohr CW. Late outcome of isolated gastric bypass. Ann Surg. 2000;231:524-528.
- Pories WJ, Swanson MS, MacDonald KG, Long SV, Morris PG, Brown BM, Barakat HA, deRamon RA, Israel G, Delezal JM, et al. Who
would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes. Ann Surg. 1995;222:339-352.